Alkermes
ALKS
#3179
Rank
C$6.41 B
Marketcap
C$38.87
Share price
-1.37%
Change (1 day)
-12.39%
Change (1 year)

Market capitalization of Alkermes (ALKS)

Market cap: C$6.41 Billion

As of December 2025 Alkermes has a market cap of C$6.41 Billion. This makes Alkermes the world's 3179th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alkermes from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$6.41 B-6.45%
2024C$6.86 B11.74%
2023C$6.14 B5.39%
2022C$5.82 B21.54%
2021C$4.79 B18.41%
2020C$4.04 B-3.7%
2019C$4.20 B-32.86%
2018C$6.26 B-40.83%
2017C$10.58 B-6.78%
2016C$11.35 B-31.6%
2015C$16.59 B65.51%
2014C$10.02 B68.11%
2013C$5.96 B144.56%
2012C$2.43 B6.57%
2011C$2.28 B95.55%
2010C$1.17 B25.17%
2009C$0.93 B-24.14%
2008C$1.23 B-21.04%
2007C$1.56 B-0.69%
2006C$1.57 B-22.94%
2005C$2.03 B33.42%
2004C$1.52 B-2%
2003C$1.55 B142.83%
2002C$0.64 B-76.24%
2001C$2.70 B0.47%
2000C$2.69 B48.82%
1999C$1.80 B150.41%
1998C$0.72 B21.85%
1997C$0.59 B0.51%
1996C$0.58 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Alkermes was reported to be:

C$6.50 Billion
by Nasdaq info icon info icon
C$6.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Acorda Therapeutics
ACOR
C$1.13 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$143.39 B 2,133.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$674.46 B 10,407.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$199.62 B 3,010.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$389.49 B 5,968.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$46.04 B 617.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
C$2.07 B-67.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$162.01 B 2,424.17%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
C$347.83 B 5,319.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland